NIH-funded research Fellowship grant

Understanding a protein linked to a neurological disorder affecting movement

Official title: Defining Human Cytochrome P450 7B1 Structure and Function to Understand Spastic Paraplegia Type 5 Disease

Funded at University of Michigan at Ann Arbor · NIH-11069674 · Data updated 2026-11-12

This study is looking at a protein that affects cholesterol levels and is important for people with spastic paraplegia type 5 (SPG5), to understand how changes in this protein can lead to the symptoms they experience, with the hope of finding better treatments for them.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2027
Funding year2025
Award (this year)$48,974
NIH project number1F31GM155958-01A1
Project IDNIH-11069674 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with spastic paraplegia type 5 due to mutations in the CYP7B1 gene.

Less likely to help

Patients with spastic paraplegia type 5 who do not have mutations in the CYP7B1 gene may not benefit from this research.

What this research studies

This research investigates the human cytochrome P450 7B1 protein, which plays a crucial role in cholesterol metabolism and is linked to spastic paraplegia type 5 (SPG5). The study aims to understand how mutations in this protein lead to the accumulation of certain cholesterol derivatives, contributing to the neurological symptoms experienced by SPG5 patients. By determining the structure of the protein and how it interacts with its substrates, researchers hope to uncover the functional defects caused by these mutations. This foundational knowledge could pave the way for developing targeted therapies for SPG5.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for patients suffering from spastic paraplegia type 5, potentially improving their quality of life.

How similar studies have gone: While the specific approach of this research is novel, similar studies investigating the role of cytochrome P450 enzymes in neurological disorders have shown promise.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Chabez, Alexandria Anastasia — University of Michigan at Ann Arbor
  • Study coordinator: Chabez, Alexandria Anastasia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.